Orthopedic Oncology & Musculoskeletal Tumors

Cancerous and non-cancerous tumors affecting bones, joints, cartilage, muscles, nerves, and soft tissues require highly specialized evaluation, making Orthopedic Oncology & Musculoskeletal Tumors an essential session in advanced musculoskeletal care. These conditions may appear as primary bone tumors, metastatic bone disease, benign lesions, soft tissue sarcomas, tumor-like abnormalities, or skeletal complications from systemic cancer. Because musculoskeletal tumors can mimic common orthopedic problems such as pain, swelling, fracture, stiffness, or reduced mobility, accurate diagnosis and timely referral are critical for patient safety and treatment success.

Specialists attending an Orthopedics Conference can use this session to explore how orthopedic oncology combines clinical examination, imaging, biopsy, pathology, staging, surgical planning, reconstruction, rehabilitation, and long-term surveillance. Tumor care often involves multiple disciplines, including orthopedic oncologists, radiologists, pathologists, medical oncologists, radiation oncologists, plastic surgeons, pain specialists, physiotherapists, nurses, and rehabilitation teams. The session supports discussion on how collaborative planning can improve limb preservation, reduce complications, and support functional recovery after tumor treatment.

A strong connection exists between this session and Musculoskeletal Tumor Care, especially when treatment decisions must balance cancer control with preservation of movement, strength, appearance, and independence. Discussions may include osteosarcoma, chondrosarcoma, Ewing sarcoma, giant cell tumor, metastatic bone disease, benign bone tumors, soft tissue sarcoma, pathological fractures, spinal tumors, pelvic tumors, and tumor-related bone defects. Each condition requires careful assessment of tumor type, location, biological behavior, patient age, functional demand, and overall health.

Diagnostic accuracy is one of the most important themes in orthopedic oncology. Imaging techniques such as X-ray, MRI, CT, PET scans, bone scans, and image-guided biopsy help define tumor extent and guide treatment planning. Poorly planned biopsy or delayed diagnosis can affect surgical options, increase recurrence risk, or complicate limb-sparing procedures. This session may address diagnostic pathways, referral red flags, biopsy principles, tumor staging, and multidisciplinary tumor board decision-making.

Treatment for musculoskeletal tumors can involve surgery, chemotherapy, radiation therapy, ablation, embolization, targeted therapy, reconstruction, or palliative care depending on diagnosis and disease stage. Limb salvage surgery, endoprosthetic reconstruction, biological reconstruction, bone grafting, custom implants, and soft tissue coverage are important areas of discussion. For metastatic disease, care may focus on pain relief, fracture prevention, stabilization, mobility preservation, and quality of life.

Rehabilitation and survivorship are equally important in tumor care. Patients may need support for walking, limb use, strength recovery, prosthetic adaptation, pain control, emotional wellbeing, and return to daily activities. Long-term follow-up helps monitor recurrence, implant performance, growth-related issues in children, treatment side effects, and functional outcomes. By addressing orthopedic oncology and musculoskeletal tumors, this session supports safer diagnosis, precise treatment planning, improved reconstruction strategies, and compassionate care for patients facing complex bone and soft tissue tumor conditions.